open access

Vol 4, No 4 (2002)
Published online: 2003-02-10
Get Citation

Efficacy of Solcoseryl in patients with pre-gangrene of lower limbs treated by vascular reconstructive surgery

Zbigniew Markiel, Krzysztof Ziaja, Dariusz Zejc, Jacek Samorodny, Marian Simka, Przemysław Nowakowski, Krzysztof Szaniewski, Wacław Kuczmik
Chirurgia Polska 2002;4(4):167-173.

open access

Vol 4, No 4 (2002)
Published online: 2003-02-10

Abstract

Background: The aim of this double-blind study was to evaluate the efficacy of intravenous injection of Solcoseryl (HD) in patients who underwent vascular reconstruction due to pre-gangrene of the lower extremities. Other surgical approaches were ineffective in these patients. In this study, the authors can establish that Solcoseryl would alleviate pain and oedema, and stimulate demarcation of necrotic tissues and healing of ulcers.
Material and methods: The study was performed in 60 patients with pre-gangrene of the lower extremities treated by reconstructive vascular surgery. Solcoseryl (20 ml/day) was administered intravenously for 15 days, in addition to routine treatment.
Results: HD-treated patients showed a significant improvement in the Doppler index, nerve conduction, oxymetry and ulcer size. There were no significant differences in the API index between HD-treated and placebo-treated patients. After 2-year follow-up in 18 HD-treated patients, 10 responded to therapy (no claudication), whereas 8 did not (persistent pain or amputation). Of 22 placebo-treated patients, 5 patients responded to therapy and 17 did not.
Conclusions: Intravenous injection of Solcoseryl in patients with pre-gangrene treated by vascular reconstruction accelerates the healing of peripheral necrotic lesions. Intravenous injection of Solcoseryl in patients with pre-gangrene of lower limbs treated by vascular reconstruction increases tissue oxygenation and alleviates the effects of prolonged ischaemia, such as persistent pain in the limb, sensory disturbances and ischaemic neuropathies.

Abstract

Background: The aim of this double-blind study was to evaluate the efficacy of intravenous injection of Solcoseryl (HD) in patients who underwent vascular reconstruction due to pre-gangrene of the lower extremities. Other surgical approaches were ineffective in these patients. In this study, the authors can establish that Solcoseryl would alleviate pain and oedema, and stimulate demarcation of necrotic tissues and healing of ulcers.
Material and methods: The study was performed in 60 patients with pre-gangrene of the lower extremities treated by reconstructive vascular surgery. Solcoseryl (20 ml/day) was administered intravenously for 15 days, in addition to routine treatment.
Results: HD-treated patients showed a significant improvement in the Doppler index, nerve conduction, oxymetry and ulcer size. There were no significant differences in the API index between HD-treated and placebo-treated patients. After 2-year follow-up in 18 HD-treated patients, 10 responded to therapy (no claudication), whereas 8 did not (persistent pain or amputation). Of 22 placebo-treated patients, 5 patients responded to therapy and 17 did not.
Conclusions: Intravenous injection of Solcoseryl in patients with pre-gangrene treated by vascular reconstruction accelerates the healing of peripheral necrotic lesions. Intravenous injection of Solcoseryl in patients with pre-gangrene of lower limbs treated by vascular reconstruction increases tissue oxygenation and alleviates the effects of prolonged ischaemia, such as persistent pain in the limb, sensory disturbances and ischaemic neuropathies.
Get Citation

Keywords

Solcoseryl; critical limb ischaemia; vascular reconstruction

About this article
Title

Efficacy of Solcoseryl in patients with pre-gangrene of lower limbs treated by vascular reconstructive surgery

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 4, No 4 (2002)

Pages

167-173

Published online

2003-02-10

Bibliographic record

Chirurgia Polska 2002;4(4):167-173.

Keywords

Solcoseryl
critical limb ischaemia
vascular reconstruction

Authors

Zbigniew Markiel
Krzysztof Ziaja
Dariusz Zejc
Jacek Samorodny
Marian Simka
Przemysław Nowakowski
Krzysztof Szaniewski
Wacław Kuczmik

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl